News
GLP-1 agonist medications such as Ozempic and Wegovy are in high demand ... 53 percent lower risk of liver cancer, 48 percent lower risk of ovarian cancer, 46 percent lower risk of colorectal ...
Fifty years of outstanding neuroscience research studies have revealed many secrets of how drugs of abuse affect and change ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
I've been hiding a secret drug habit. Once a week I sneak off and jab myself with a syringe I bought online. I only told my ...
EXCLUSIVE: The dialysis company believes the impact of the treatments on its own performance will be ‘neutral to positive’ ...
Head of the Metabolic Neuroscience Laboratory, investigates the brain ‘goo’ behind obesity and Type-2 diabetes - and how we ...
Cathey Chustz, a lifelong Baton Rouge local, has been married 44 years and has two grown daughters and two young ...
Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.
3d
Zacks Investment Research on MSNNovo Nordisk Stock Rises 6% in a Week: What Should Investors Do?Novo Nordisk NVO shares have gained 5.8% in a week. The uptrend in the stock price was driven by reports of an activist hedge ...
With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways ...
Q. I’ve been on Ozempic for several months now. My blood sugar in the morning is around 103, down from about 180 before. I’ve lost 30 pounds. The weight off my knees has been great. Initially, I had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results